Effect of pCMV AIM-1 antisense Constructs on Human Ovarian Cancer Xenografts Growth in Nude Mice
-
摘要: 目的 探讨pCMV AIM-1 antisence重组质粒对卵巢癌裸鼠移植瘤的体内抑瘤效应。方法 （1）人卵巢癌细胞A2780转染pCMV空载体和pCMV AIM-1 antisense重组质粒，G418筛选出抗性克隆，扩增后产生的稳定转染株用于实验；（2）通过RT-PCR、Western blot检测未转染A2780细胞（对照组）、A2780转染pCMV空载体和pCMV AIM-1 antisense重组质粒三组AIM-1 mRNA和蛋白的表达；（3）将稳定转染的pCMV空载体和pCMV AIM-1 antisense重组质粒的A2780细胞注入裸鼠皮下，建立裸鼠移植瘤模型，未转染A2780细胞注入裸鼠皮下作为对照，观察三组裸鼠移植瘤生长情况，计算肿瘤重量和肿瘤体积，并进行统计对比分析；（4）SP免疫组织化学法检测移植瘤组织切片AIM-1的表达。结果 （1）A2780对照组转染pCMV空载体组AIM-1 mRNA和蛋白表达无明显改变；而A2780转染pCMV AIM-1 antisense重组质粒组细胞AIM-1 mRNA和蛋白表达明显下降；（2）A2780对照组、A2780转染pCMV空载体组和A2780转染pCMV AIM-1 antisense重组质粒组的裸鼠肿瘤重量分别为（1.93±0.21）g、（1.90±0.39）g和(0.77±0.34）g；移植瘤体积分别为（1 011.7±235.6）mm3、（981.2±162.3）mm3和（468.7±119.6）mm3，重组质粒组与空载体组和对照组相比，差异有统计学意义（P<0.01）；pCMV AIM-1 antisense重组质粒的抑瘤率达53.8%。（3）SP免疫组织化学法检测瘤体组织切片AIM-1的表达情况，见A2780对照组和转染pCMV空载体组AIM-1表达没有明显改变，而A2780转染pCMV AIM-1antisense重组质粒组AIM-1的表达明显减少。重组质粒组AIM-1蛋白表达阳性率和阳性标记指数均明显低于对照组和空载体组（P<0.01）。 结论 pCMV AIM-1 antisense重组质粒对A2780移植瘤生长有明显抑制作用。Abstract: Objective To explore the effect of pCMV AIM-1 antisense constructs on human ovarian cancer xenografts growth in nude mice. Methods pCMV empty plasmids and pCMV AIM-1 antisense constructs were transfected into human ovarian cancer cells A2780, then the cells were trypsinized and expanded, and stable transfectants were generated after 400μg/ml geneticin(G418) screening. The clones carrying antisense plasmid were then selected for further experiments. RT-PCR and Western blot were used to examine the expression of AIM-1 mRNA and protein in three groups(each n=8); A2780 control group, A2780-pCMV empty plasmids and A2780-pCMV AIM-1 antisense group. Mouse tumor model was established by transferring human ovarian cancer cells A2780 or A2780-pCMV empty plasmids or A2780-pCMV AIM-1 antisense subcutaneously into the oxter of nude mice. The tumor growth, volumes and weights of subcutaneous tumor xenografts were detected. The expression of AIM-1 was detected by Streptavidinbiotin peroxidase(SP) immunohistochemical technique. Results (1)The mRNA and protein expression levels of AIM-1 were obviously silenced in A2780-pCMV AIM-1 antisense group, while no change in other two groups; (2)The tumor weight in A2780 control, A2780-pCMV empty plasmids and A2780-pCMV AIM-1 antisense groups were (1.93±0.21), (1.90±0.39) and (0.77±0.34)g, respectively; The tumor volume were (1 011.7±235.6), (981.2±162.3) and (468.7±119.6)mm3, respectively. There were significant differences in tumor weight and volume between A2780-pCMV AIM-1 antisense group and other two groups(P<0.01). The anti-tumor rate of pCMV AIM-1 antisense group could reach to 53.8%. The AIM-1 expression in A2780-pCMV AIM-1 antisense group was radically reduced, compared with A2780-pCMV empty plasmids and A2780 control groups. The positive rate and positive labeling index(PLI) of AIM-1 protein expression in A2780-pCMV AIM-1 antisense group were significantly lower than those in other two groups(P<0.01). Conclusion The pCMV AIM-1 antisense constructs suppresses the tumor xenografts growth in nude mice.
-
Key words:
- Plasmid vector /
- AIM-1 /
- Tumor xenografts /
- Nude mice
-
-
[1] Hégarat N, Smith E, Nayak G, et al. Aurora A and Aurora B jointly coordinate chromosome segregation and anaphase microtubule dynamics[J]. J Cell Biol, 2011, 195(7): 1103-13. [2] Wu Q, Zhang W, Mu T, et al. Aurora B kinase is required for cytokinesis through effecting spindle structure[J]. Cell Biol Int, 20 13, 37(5): 436-42. [3] Qi G, Ogawa I, Kudo Y, et al. Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer[J]. Virchows Arch, 2007, 450(3): 297-302. [4] Sabino D, Brown NH, Basto R. Drosophila Ajuba is not an Aurora-A activator but is required to maintain Aurora-A at the centrosome[J]. J Cell Sci, 2011, 124(Pt 7): 1156-66. [5] Baratchi S, Kanwar RK, Kanwar JR. Survivin: a target from brain cancer to neurodegenerative disease[J]. Crit Rev Biochem Mol Biol, 2010, 45(6): 535-54. [6] Yin JQ, Gao J, Shao R, et al. siRNA agents inhibit oncogene expression and attenuate human tumor cell growth[J]. J Exp Ther Oncol, 2003, 3(4): 194-204. [7] Kollareddy M, Zheleva D, Dzubak P, et al. Aurora kinase inhibitors: progress towards the clinic[J]. Invest New Drugs, 20 12, 30(6): 2411-32. [8] Collette KS, Petty EL, Golenberg N, et al. Different roles for Aurora B in condensin targeting during mitosis and meiosis[J]. J Cell Sci, 2011, 124(Pt 21): 3684-94. [9] Adams RR, Maiato H, Earnshaw WC, et al. Essential roles of Drosophila inner centromere protein (INCENP) and aurora B in histone H3 phosphorylation, metaphase chromosome alignment, kinetochore disjunction, and chromosome segregation[J]. J Cell Biol, 2001, 153(4): 865-80. [10] Snoek R, Cheng H, Margiotti K, et al. In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors[J]. Clin Cancer Res, 2009, 15(1): 39-47. [11] Liu TG, Yin JQ, Shang BY, et al. Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer[J]. Cancer Gene Ther, 2004, 11(11): 748-56. [12] Terakawa T, Miyake H, Kumano M, et al. Growth inhibition and enhanced chemosensitivity induced by down-regulation of Aurora-A in human renal cell carcinoma Caki-2 cells using short hairpin RNA[J]. Oncol Lett, 2011, 2(4): 713-7. [13] Shen YM, Yang XC, Song ML, et al. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells[J]. Hepatobiliary Pancreat Dis Int, 2010, 9(1): 69-77.
计量
- 文章访问数: 1351
- HTML全文浏览量: 325
- PDF下载量: 553
下载:
